Why People Who Use Cannabis Often Use Other Drugs: Genetics Says It's Not Just a Gateway
A twin study of over 2,100 pairs found that the relationship between cannabis and other drug use was best explained by shared genetic and environmental risk factors rather than cannabis directly causing progression to harder drugs.
Quick Facts
What This Study Found
Using data from 1,191 male and 934 female same-sex twin pairs, researchers tested 13 genetically informative models of comorbidity between cannabis and other illicit drug use. The correlated liabilities model, which posits shared genetic and environmental risk factors, provided a good fit for both drug use and abuse/dependence.
The pure gateway model (in which cannabis use directly causes other drug use) did not adequately explain the data. However, there was some evidence that among high-risk cannabis users, cannabis use might increase the likelihood of other drug use. For abuse and dependence specifically, a model including causal pathways between cannabis and other drug liability also fit well, suggesting the relationship may be more complex for problematic use than for casual use.
Key Numbers
1,191 male and 934 female same-sex twin pairs. Thirteen models tested. Correlated liabilities model fit best for both use and abuse/dependence.
How They Did This
This was a twin study using 1,191 male and 934 female same-sex twin pairs. Thirteen genetically informative structural equation models were compared, including gateway models, correlated liabilities models, and hybrid models. Models were fit separately for use and abuse/dependence in both sexes.
Why This Research Matters
This study provided some of the strongest genetic evidence against a simple gateway model of drug progression. By using twins to separate genetic from environmental influences, it showed that shared vulnerabilities, rather than cannabis exposure itself, largely explained why cannabis users were more likely to use other drugs.
The Bigger Picture
This study added to a growing body of twin and genetic research suggesting that the gateway theory of drug progression oversimplifies a complex relationship driven by shared risk factors. This has implications for drug policy: if cannabis use does not directly cause progression to harder drugs, then preventing cannabis use alone would not necessarily prevent other drug use.
What This Study Doesn't Tell Us
Twin studies estimate genetic effects at the population level and cannot identify specific genes. The cross-sectional design limited the ability to establish temporal relationships. The finding that some gateway-like effects might exist for abuse/dependence complicated the interpretation.
Questions This Raises
- ?Do specific shared genetic variants link cannabis and other drug vulnerabilities?
- ?Is the partial gateway effect for abuse/dependence clinically meaningful?
- ?How do these findings differ by sex?
Trust & Context
- Key Stat:
- Shared risk factors model fit better than gateway model across 13 tested models
- Evidence Grade:
- This is a well-powered twin study with over 2,000 pairs testing multiple competing models, providing moderate-level evidence.
- Study Age:
- Published in 2004. Subsequent genomic studies have begun identifying specific genetic variants linked to substance use risk.
- Original Title:
- Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females.
- Published In:
- Behavior genetics, 34(3), 217-28 (2004)
- Authors:
- Agrawal, Arpana(39), Neale, Michael C(6), Prescott, Carol A, Kendler, Kenneth S
- Database ID:
- RTHC-00154
Evidence Hierarchy
A snapshot of a population at one point in time.
What do these levels mean? →Frequently Asked Questions
Is cannabis a gateway drug?
This twin study found that the simple gateway model did not adequately explain why cannabis users are more likely to use other drugs. Shared genetic and environmental risk factors provided a better explanation, meaning the same vulnerabilities that lead to cannabis use also independently increase risk for other drug use.
What is the correlated liabilities model?
It proposes that cannabis and other drug use share common underlying risk factors (genetic predisposition, environmental circumstances) rather than one substance directly causing use of another. The same person who is predisposed to cannabis use is also predisposed to other drug use for the same underlying reasons.
Read More on RethinkTHC
- cannabis-dependence-physical-psychological-addiction-science
- cannabis-perception-vs-evidence-gap
- cannabis-use-disorder-test
- cross-addiction-quit-weed-start-drinking
- is-weed-addictive
- is-weed-addictive-science
- quitting-weed-and-alcohol
- rehab-for-weed-addiction-necessary
- signs-of-cannabis-use-disorder
- weed-vape-pen-addiction
Cite This Study
https://rethinkthc.com/research/RTHC-00154APA
Agrawal, Arpana; Neale, Michael C; Prescott, Carol A; Kendler, Kenneth S. (2004). Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females.. Behavior genetics, 34(3), 217-28.
MLA
Agrawal, Arpana, et al. "Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females.." Behavior genetics, 2004.
RethinkTHC
RethinkTHC Research Database. "Cannabis and other illicit drugs: comorbid use and abuse/dep..." RTHC-00154. Retrieved from https://rethinkthc.com/research/agrawal-2004-cannabis-and-other-illicit
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.